ALLMedicine™ Onychomycosis Center
Research & Reviews 1,551 results
https://doi.org/10.1208/s12249-020-01893-9 10.1001/archderm.1997.03890460029004 10.1016/j.jaad.2014.01.893 10.1016/S1085-5629(97)80043-0 10.2165/00128071-200405040-00003 10.1186/1471-2334-7-102 10.1111/j.1439-0507.2007.01405.x 10.1016/J.NHTM.2017.01.002 10.3109/03639045.2011.637931 10.1111/j.1468-3083.2004.00988.x 10.3109/08982101003596125 10.3109/03639045.2013.788016 10.1016/j.ejps.2013.08.032 10.1016/j.ejps.2007.07.009 10.3390/pharmaceutics10040273 10.1208/s12249-016-0528-9 10.1208/s12249-013-9964-y 10.22159/ijpps.2019v11i12.35560 10.1208/s12249-013-9954-0 10.1016/j.ijpharm.2009.10.018 10.1016/j.colsurfb.2010.12.024 10.1016/j.ijpharm.2010.11.036 10.1590/s2175-97902017000115012 10.1186/s12879-015-1240-1 10.1111/j.1574-695X.2000.tb01529.x 10.1208/s12249-011-9742-7 10.3109/10717544.2014.914601 10.1208/s12249-011-9583-4 10.3109/21691401.2013.794351 10.3109/03639045.2014.931966 10.1016/j.ijpharm.2012.06.020 10.1016/j.jchromb.2009.09.032 10.1159/000324055 10.1016/j.jare.2016.03.003 10.1038/jid.1961.153 10.3109/10717544.2015.1099059 10.1166/jnd.2013.1031 10.2147/IJN.S68737 10.1016/j.ejpb.2012.06.015 10.22159/ajpcr.2018.v11s3.30040 10.4103/0975-1483.83765 10.1016/j.ejpb.2004.11.002 10.9734/BJPR/2013/2770
AAPS PharmSciTech; Abobakr FE, Fayez SM et. al.
Jan 6th, 2021 - Onychomycosis is considered a stubborn nail fungal infection that does not respond to conventional topical antifungal treatments. This study aimed to develop and characterize novel solid lipid nanoparticles (SLNs) formulae containing terbinafine H...
https://www.ncbi.nlm.nih.gov/pubmed/33397567
Skinmed Geizhals S, Lipner SR
Jan 5th, 2021 - Onychomycosis was first described in the mid-1800's, and early treatment regimens involved applying corrosive substances and nail plate avulsion. It was not until the mid-1900's that more specific antifungal agents were utilized. Initially, only o...
https://doi.org/10.1097/MJT.0000000000001291
American Journal of Therapeutics; Jiang W, Yang Q et. al.
Jan 4th, 2021 - The Effectiveness of Long-Pulse 1064 nm Nd-YAG Laser Therapy Combined With an Oral Itraconazole Capsule in the Treatment of Onychomycosis.|2021|Jiang W,Yang Q,Cai H,Xu Q,Ju A,|
https://doi.org/10.1111/ijd.15387
International Journal of Dermatology References; Nikhila PK, Sukumarakurup S et. al.
Dec 30th, 2020 - The pattern of dermatoses among underwater workers is undocumented and, hence, worth studying. The objective of the study was to document the pattern of dermatoses among underwater workers in a tropical seaside area. A population-based cross-secti...
https://doi.org/10.1007/s40257-020-00580-6 10.4103/ijdvl.IJDVL_224_17 10.4103/ijd.IJD_206_17 10.1111/j.1439-0507.2008.01606.x 10.1128/MMBR.00016-10 10.1007/s11046-008-9100-9 10.1111/myc.12878 10.1111/j.1540-9740.2005.03435.x 10.1128/AAC.47.1.82-86.2003 10.1128/AAC.01600-05 10.1111/myc.12772 10.1128/AAC.00115-17 10.1128/AAC.02522-17 10.1111/1346-8138.14809 10.1016/j.mmcr.2019.09.001 10.1016/j.mycmed.2019.100903 10.1128/AAC.01126-19 10.1007/s00105-019-4431-7 10.1111/bjd.19146 10.1111/myc.13091 10.1007/s10096-018-3317-4 10.1016/j.mmcr.2017.07.003 10.4103/0019-5154.190120 10.4103/ijdvl.IJDVL_526_17 10.1128/AAC.01038-18 10.2147/IDR.S246025 10.1111/dth.14014 10.1111/pde.13411 10.2340/00015555-2455 10.1093/mmy/myx044 10.1111/bjd.19420 10.1111/myc.12794 10.1111/jdv.16394 10.1080/09546634.2019.1612835 10.1093/jac/dkaa111 10.1111/j.1439-0507.2006.01295.x 10.1007/s11046-016-0045-0 10.1016/j.ijantimicag.2017.03.021 10.2147/IDR.S61998 10.1128/AAC.02056-12 10.12688/f1000research.18646.1 10.1177/1203475417716362 10.1016/j.pdpdt.2020.101774 10.4103/ijdvl.IJDVL_853_18 10.1111/ced.13780
American Journal of Clinical Dermatology; Gupta AK, Renaud HJ et. al.
Dec 23rd, 2020 - Superficial mycoses are becoming increasingly resistant to current antifungal medications. As alternative therapeutic options are limited, the increasing frequency of reports of antifungal resistance is alarming. This epidemic parallels the rise o...
Guidelines 2 results
https://www.cdc.gov/fungal/nail-infections.html
Jan 24th, 2017 - Fungal nail infections, also called onychomycosis, are common infections of the fingernails or toenails that can cause the nail to become discolored, thick, and more likely to crack and break.
https://doi.org/10.1111/bjd.13358
The British Journal of Dermatology; Ameen M, Lear JT et. al.
Nov 20th, 2014 - British Association of Dermatologists' guidelines for the management of onychomycosis 2014.|2014|Ameen M,Lear JT,Madan V,Mohd Mustapa MF,Richardson M,|administration & dosage,diagnosis,drug therapy,surgery,complications,diagnosis,drug therapy,surg...
Drugs 199 results see all →
Clinicaltrials.gov 1,795 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80aab848-8739-4259-a092-ed99d0f6a56d
Jan 12th, 2021 - Terbinafine tablets, USP are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc68c727-a77a-432e-8308-e88aea241b58
Jan 10th, 2021 - Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes. Tavaborole topical solution is an oxaborole antifungal indicated for...
https://doi.org/10.1208/s12249-020-01893-9 10.1001/archderm.1997.03890460029004 10.1016/j.jaad.2014.01.893 10.1016/S1085-5629(97)80043-0 10.2165/00128071-200405040-00003 10.1186/1471-2334-7-102 10.1111/j.1439-0507.2007.01405.x 10.1016/J.NHTM.2017.01.002 10.3109/03639045.2011.637931 10.1111/j.1468-3083.2004.00988.x 10.3109/08982101003596125 10.3109/03639045.2013.788016 10.1016/j.ejps.2013.08.032 10.1016/j.ejps.2007.07.009 10.3390/pharmaceutics10040273 10.1208/s12249-016-0528-9 10.1208/s12249-013-9964-y 10.22159/ijpps.2019v11i12.35560 10.1208/s12249-013-9954-0 10.1016/j.ijpharm.2009.10.018 10.1016/j.colsurfb.2010.12.024 10.1016/j.ijpharm.2010.11.036 10.1590/s2175-97902017000115012 10.1186/s12879-015-1240-1 10.1111/j.1574-695X.2000.tb01529.x 10.1208/s12249-011-9742-7 10.3109/10717544.2014.914601 10.1208/s12249-011-9583-4 10.3109/21691401.2013.794351 10.3109/03639045.2014.931966 10.1016/j.ijpharm.2012.06.020 10.1016/j.jchromb.2009.09.032 10.1159/000324055 10.1016/j.jare.2016.03.003 10.1038/jid.1961.153 10.3109/10717544.2015.1099059 10.1166/jnd.2013.1031 10.2147/IJN.S68737 10.1016/j.ejpb.2012.06.015 10.22159/ajpcr.2018.v11s3.30040 10.4103/0975-1483.83765 10.1016/j.ejpb.2004.11.002 10.9734/BJPR/2013/2770
AAPS PharmSciTech; Abobakr FE, Fayez SM et. al.
Jan 6th, 2021 - Onychomycosis is considered a stubborn nail fungal infection that does not respond to conventional topical antifungal treatments. This study aimed to develop and characterize novel solid lipid nanoparticles (SLNs) formulae containing terbinafine H...
https://www.ncbi.nlm.nih.gov/pubmed/33397567
Skinmed Geizhals S, Lipner SR
Jan 5th, 2021 - Onychomycosis was first described in the mid-1800's, and early treatment regimens involved applying corrosive substances and nail plate avulsion. It was not until the mid-1900's that more specific antifungal agents were utilized. Initially, only o...
https://doi.org/10.1097/MJT.0000000000001291
American Journal of Therapeutics; Jiang W, Yang Q et. al.
Jan 4th, 2021 - The Effectiveness of Long-Pulse 1064 nm Nd-YAG Laser Therapy Combined With an Oral Itraconazole Capsule in the Treatment of Onychomycosis.|2021|Jiang W,Yang Q,Cai H,Xu Q,Ju A,|
News 201 results
https://www.staging.medscape.com/viewarticle/935774
Aug 16th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...
https://www.medscape.com/viewarticle/935774
Aug 16th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...
https://reference.medscape.com/viewarticle/935244
Aug 13th, 2020 - Dupixent (dupilumab) - Indicated for moderate-to-severe atopic dermatitis not adequately controlled with topical prescription therapies or when those therapies are not advisable in children aged 6 years or older. Jublia (efinaconazole) - Indicatio...
https://www.staging.medscape.com/viewarticle/932903
Jun 23rd, 2020 - There appear to be no differences in efficacy or safety between pulse and continuous regimens of terbinafine and no differences between pulse and continuous regimens of itraconazole for dermatophyte toenail onychomycosis, results from a systematic...
https://www.mdedge.com/familymedicine/article/218427/oncology/nail-growth?channel=203
MDedge Family Medicine;
Mar 5th, 2020 - The treatment failure with the terbinafine made onychomycosis unlikely, and the appearance of the finger did not suggest that this was a wart. So, the physician opted for a 4-mm punch biopsy of the lateral nail fold, which confirmed that this was.